chrX-155511727-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_018196.4(TMLHE):c.704C>A(p.Thr235Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000371 in 1,200,801 control chromosomes in the GnomAD database, including 1 homozygotes. There are 109 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 1 hom., 55 hem., cov: 22)
Exomes 𝑓: 0.00021 ( 0 hom. 54 hem. )
Consequence
TMLHE
NM_018196.4 missense
NM_018196.4 missense
Scores
5
8
4
Clinical Significance
Conservation
PhyloP100: 5.33
Genes affected
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03219667).
BP6
Variant X-155511727-G-T is Benign according to our data. Variant chrX-155511727-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 507632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-155511727-G-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 222 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMLHE | NM_018196.4 | c.704C>A | p.Thr235Asn | missense_variant | 5/8 | ENST00000334398.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMLHE | ENST00000334398.8 | c.704C>A | p.Thr235Asn | missense_variant | 5/8 | 1 | NM_018196.4 | P1 | |
TMLHE | ENST00000369439.4 | c.704C>A | p.Thr235Asn | missense_variant | 5/7 | 1 | |||
TMLHE-AS1 | ENST00000452506.1 | n.67+22338G>T | intron_variant, non_coding_transcript_variant | 5 | |||||
TMLHE | ENST00000675642.1 | c.737C>A | p.Thr246Asn | missense_variant | 6/9 |
Frequencies
GnomAD3 genomes AF: 0.00199 AC: 222AN: 111707Hom.: 1 Cov.: 22 AF XY: 0.00162 AC XY: 55AN XY: 33945
GnomAD3 genomes
AF:
AC:
222
AN:
111707
Hom.:
Cov.:
22
AF XY:
AC XY:
55
AN XY:
33945
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000535 AC: 97AN: 181208Hom.: 1 AF XY: 0.000304 AC XY: 20AN XY: 65876
GnomAD3 exomes
AF:
AC:
97
AN:
181208
Hom.:
AF XY:
AC XY:
20
AN XY:
65876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000206 AC: 224AN: 1089045Hom.: 0 Cov.: 28 AF XY: 0.000152 AC XY: 54AN XY: 356035
GnomAD4 exome
AF:
AC:
224
AN:
1089045
Hom.:
Cov.:
28
AF XY:
AC XY:
54
AN XY:
356035
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00199 AC: 222AN: 111756Hom.: 1 Cov.: 22 AF XY: 0.00162 AC XY: 55AN XY: 34004
GnomAD4 genome
AF:
AC:
222
AN:
111756
Hom.:
Cov.:
22
AF XY:
AC XY:
55
AN XY:
34004
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
31
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
74
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TMLHE-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 27, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;H
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at